AI-Powered Pharmacovigilance System Development

Pharmaceutical companies must monitor adverse drug reactions (ADRs) from tens of thousands of sources—FAERS spontaneous reports, PubMed clinical articles, social media posts. Manual processing takes up to 90 minutes per report, yet serious cases must be submitted to the FDA within 15 days. Our AI pharmacovigilance automation accelerates this process 10-fold, automatically generate CIOMS reports, and cut operational costs by 60–80% (saving up to $500,000 annually for a mid-size pharma). Full development starting from $50,000. Our system supports CIOMS auto-filling for regulatory submission.

What core problems does the AI pharmacovigilance solve?

First, data volume. FAERS contains over 10 million reports, with thousands added daily. Manual signal detection is impossible. Second, unstructured data. Reports contain typos, abbreviations, and informal language (especially from social media). Third, compliance timelines. For serious unexpected ADRs, deadlines are tight. Our drug safety monitoring system pipeline reduces processing time from 45–90 minutes to 5–10 minutes with verification. Our NLP for adverse drug reactions capability handles diverse text formats.

Safety signal extraction methods

We use fine-tuned BioBERT for NLP tasks: drug name recognition, MedDRA coding, and causality assessment. MedDRA coding accuracy reaches F1 0.82–0.88. For social media, we apply classifiers to distinguish ADR reports from mentions without reaction. The pipeline includes negation detection (e.g., "patient did not experience nausea") and attribute attachment to the drug. This is our core adverse reaction extraction capability.

ML signal detection vs. traditional methods

Traditional disproportionality methods (PRR, ROR, BCPNN) do not account for confounding factors or temporal trends. Our ML signal detection models based on sparse matrices and neural networks detect signals 3 times faster. For example, acetaminophen hepatotoxicity would have been detected 18 months earlier with ML analysis. We also apply gradient boosting for signal prioritization by criticality. Our FAERS analysis pipeline integrates with EudraVigilance monitoring for cross-database signal validation.

What is included in the development package?

Our development package includes full project documentation (system architecture, model cards, API specs), access to trained models and source code, team training sessions, and post-deployment support for 3 months. We also provide MLOps pipeline setup and integration with your existing systems.

How does the development process work?

In practice, the process unfolds as follows: first, we analyze data sources and regulations (2–4 weeks), then design the NLP pipeline architecture (3–6 weeks), implement ADR extraction and signal detection modules (8–16 weeks), validate with A/B testing (4–6 weeks), and finally deploy on the client's infrastructure (2–4 weeks).

Full development takes 4 to 8 months. Pricing starts at $50,000, with potential annual savings of up to $500,000.

Signal detection methods comparison

We also integrate MLOps practices: model versioning via MLflow, A/B tests on historical data, data drift monitoring. This ensures production stability.

Case study

For one client, we implemented a literature monitoring system. PubMed publishes thousands of articles daily. Manual screening took 2 hours per day. Our pipeline automatically downloads articles by keywords (drug + ADR), classifies relevance (filtering 90% irrelevant ones), and creates an expert queue. Analysis time dropped from 2 hours to 10 minutes (12x improvement). The system also drafts PSUR reports by aggregating all ADRs for the period. We used DistilBERT fine-tuned on a clinical annotation corpus, achieving F1 0.85 on relevance classification. Our system is 10 times more efficient than manual report processing.

Typical pitfalls in pharmacovigilance AI implementation

1. Neglecting negation handling: A simple keyword search may flag "no adverse events" as an ADR. Our pipeline explicitly models negation scope.
2. Ignoring temporal decay: Historical signals may not be relevant today. We incorporate time weighting in signal detection.
3. Overlooking data privacy: Social media data requires anonymization. We implement de-identification before processing.
4. Insufficient validation: Models must be validated on real-world data from the specific therapeutic area. We perform A/B testing against manual expert review.

Results and guarantees

With over 10+ years of experience in pharmaceutical AI and 50+ projects completed, we guarantee transparency: you receive model cards, pipeline documentation, and team training. Our engineers are certified in AWS and Google Cloud, with 5+ years of MLOps experience in pharma. We are a reliable partner with 5 years on the market. Request a consultation for a free project evaluation.

Industry AI Solutions: Healthcare, Finance, Retail, Manufacturing

We encounter the same pain points: a general text model doesn’t distinguish medical nomenclature, and a standard object detector confuses “weld seam scratch” with “casing scratch.” Each time these are different defects with different consequences. To avoid this, we build industry-specific solutions on top of general methods, but with deep domain knowledge — from regulatory requirements to data specifics. Over 5 years, we have completed 80+ projects in fintech, healthcare, retail, and manufacturing, and none were without adaptation to a specific business case.

Healthcare: Regulatory Maze and Data Governance

Medical AI differs not in technical algorithms but in a compliance-first approach. Depending on the country of application, the model may be a Class II or III medical device requiring clinical trials (FDA, CE MDR, GOST R). We ensure compliance with these standards at the architecture stage — fixing them post-factum is 10× more expensive.

Medical imaging. Detection on X‑rays, CT, MRI is a mature area. Models on ResNet, EfficientNet, SegFormer achieve AUC 0.94–0.97 on standard tasks (pneumonia on CXR, polyps on colonoscopy). Key issue is generalization: a model trained on data from one scanner manufacturer degrades on another due to differences in preprocessing and artifacts. Solution: domain adaptation via MONAI (Medical Open Network for AI) from NVIDIA, which includes DICOM loading, 3D augmentation, and confidence calibration. TotalSegmentator — for automatic segmentation of 117 structures on CT, production‑ready, Apache 2.0 license.

Clinical NLP. Extracting structured information from clinical records: diagnoses (ICD‑10/11), prescriptions, dates, indicators. medspaCy, scispaCy, MedCAT — specialized NLP libraries with ontologies (SNOMED‑CT, UMLS). Fine‑tuning BioBERT or ClinicalBERT on our data yields F1 0.85–0.92 on NER tasks versus F1 0.65–0.72 for general BERT. We verified this on a project with a regional oncology center — cancer stage extraction accuracy increased by 23%.

Clinical decision support. LLM assistants for clinical decision support are a regulatory gray area. We use an RAG system on top of clinical guidelines (UpToDate, local protocols) with explicit citation for each statement. The model does not diagnose but helps find relevant protocols. Stack: LlamaIndex + pgvector + pubmedbert-base-embeddings + Llama Guard for safety. Data in DICOM/HL7 FHIR, on‑premise deployment mandatory.

Finance: How to Ensure Interpretability of a Scoring Model under Basel IV?

The financial sector is one of the most mature in applying ML, but regulation is maximal. Every model affecting credit decisions falls under Basel IV, EU AI Act, GDPR Article 22. We deliver AI solutions for fintech that satisfy these requirements — in a project for a top‑10 bank we deployed a scoring model where each record required SHAP explanations.

Credit scoring. Gradient boosting (LightGBM, XGBoost) dominates. Neural networks yield +0.5–2% AUC but lose interpretability. Standard: LightGBM + SHAP to explain each decision. Fairness checking is mandatory: Fairlearn or aif360 for auditing disparate impact on protected attributes (age, gender). The default class is 1–5% — with an imbalance of 1:30, a model with 97% accuracy may have recall 0.2. Solution: focal loss, class_weight='balanced', SMOTE + careful validation. In one fintech scoring project, the model reduced credit losses by $2.1 million annually.

Algorithmic trading and risk management. LSTM and Transformer for price forecasting are popular but unstable in production due to non‑stationarity of financial series. A more robust approach: ML for signal generation (classification: up/down over horizon N) with traditional portfolio optimization on top. Backtesting via Zipline‑Reloaded, vectorbt, QuantLib. Proper backtesting is critical — look‑ahead bias kills results. We guarantee a clean experiment: all data at signal time is available in real time.

AML (Anti‑Money Laundering). Graph Neural Networks for analyzing transaction networks is an actively developing area. PyG, DGL for GNN. Task: detect suspicious patterns in transaction graphs (layering, structuring). Recall is more critical than precision — better 10 false alarms than miss one money laundering. In a project for a large payment service, we increased recall by 18% without increasing false positive rate.

Retail and e‑commerce: Recommendation Systems and Demand Forecasting

Recommendation systems. Current architectural standard: two‑tower model for retrieval + ranking with cross‑features. TensorFlow Recommenders or Merlin from NVIDIA for GPU‑accelerated feature processing. For small catalogs (<100k items), LightFM is sufficient. A common mistake is training on implicit feedback without accounting for position bias. Solution: IPW (Inverse Propensity Weighting) or randomized logging on a portion of traffic. Development time for a basic recommendation system is 4–8 weeks, including A/B test.

Demand forecasting and inventory optimization. Hierarchical forecasting: SKU → category → store → region. HierarchicalForecast from Nixtla automatically reconciles forecasts across levels. TFT or N‑HiTS for base forecast, gradient boosting for adjustment on exogenous factors (promotions, weather, events). One retail project led to a 15% reduction in stock‑outs due to precise promotion calibration.

Visual search and size compatibility. CLIP embeddings for image search — deploy in 2–3 weeks: clip‑ViT‑B‑32 or clip‑ViT‑L‑14, Faiss or Qdrant index, REST API. For size recommendation — specific models on return data and reviews with fit indication.

Manufacturing: Quality Inspection and Predictive Maintenance

Quality control and defect detection. CV models for product inspection are one of the most mature industry tasks. YOLOv10 for defect detection, SegFormer for segmentation. Specifics: class imbalance (defects are rare), high recall requirement (missing a defect is worse than false alarm). Typical dataset: 500–2000 defect images + 500–1000 normal. Few‑shot learning via DINO or SAM 2 works with 50–100 annotated examples. We gained experience on an electronics production line — recall 0.95 at FPR 0.03. A predictive maintenance deployment saved a manufacturing client $500,000 per year in unplanned downtime.

Predictive maintenance. Vibration sensors, current sensors, thermocouples → feature extraction → anomaly or mode classification. Models: LSTM‑AE for unsupervised, LightGBM for supervised (if failure history is available). Integration with SCADA/OPC‑UA via opcua-asyncio or MQTT. Key metric: False Negative Rate — a missed pre‑failure is more costly than a false alarm. Threshold tuned to business cost of each error type. Timeline: 3 to 6 months to production.

Digital twin and simulation. Surrogate models — ML models replacing expensive physical simulation. If a CFD simulation takes 6 hours and a surrogate (trained on 10,000 simulations) takes 0.01 seconds, that's 2,000,000× speedup for optimization. SALib for sensitivity analysis, botorch for Bayesian optimization on top of surrogate.

General Principles of Industry AI

Regardless of industry, there are patterns that work everywhere. Data matters more than architecture. In healthcare, 1000 quality labeled images are better than 100,000 poor ones. In manufacturing, 200 real defect examples are more valuable than 10,000 synthetic ones. Compliance‑first design — regulatory requirements are easier to embed into architecture from the start than to add later. Logging, explainability, versioning from day one. Domain expert on the team — an ML engineer without domain knowledge does slowly and error‑prone what an ML engineer plus a doctor/financier/technologist does quickly and correctly.

We guarantee certification to customer requirements (ISO 13485, SOC 2, GDPR) and provide full model documentation (model card, datasheet, compliance report). Our experience: 10,000+ engineering hours and 80+ projects.

Work Process for an Industry AI Solution

1. Domain immersion (2–3 days) — interviews with experts, studying regulatory requirements, auditing available data.
2. MVP design (1–2 weeks) — stack and architecture selection, feasibility assessment.
3. Development and validation (from 4 weeks to 6 months depending on industry) — model training, testing, compliance.
4. Integration and deployment (1–4 weeks) — on‑premise / cloud / edge, documentation, staff training.
5. Support and monitoring — model drift, retraining, SLA.

Estimated timelines:

Cost is calculated individually for each project. Get a consultation — we will evaluate your dataset, regulatory map, and business goals.

Why Choose Our Industry AI Solutions?

• 80+ completed projects in fintech, healthcare, retail, and manufacturing.
• 5 years on the market — proven experience with compliance and deployment.
• Quality guarantee: we ensure target metrics (AUC, recall, latency p99) and provide full documentation.
• Licensed technologies: PyTorch, MONAI, LightGBM, Qdrant — we use open‑source with commercially safe licenses.
• Flexibility: we work as a contractor or as an extension of your team.

Contact us for a free data audit and consultation. Request a proposal with a detailed work plan. We will discuss your task and prepare a commercial proposal.